When Will Novavax Be Available

News

FDA, Novavax and COVID-19 vaccine

Novavax told by FDA to conduct additional study for COVID vaccine - report

The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine before it will consider approving it. The prospect is a major setback for the biotech as it would be costly for the company to complete.

Medical Xpress · 10h

Novavax COVID vaccine moves closer to full FDA approval

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday.

Markets Insider · 7h

Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in

The Business Journals2d

Novavax's stock surges on 'good news' from Food and Drug Administration

Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from the U.S. Food and Drug Administration is important to both Novavax ...

15don MSN

Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

Yahoo Finance4d

Why the Market Dipped But Novavax (NVAX) Gained Today

Novavax (NVAX) closed the most recent trading day at $6.01, moving +0.17% from the previous trading session. This change outpaced the S&P 500's 2.36% loss on the day. Elsewhere, the Dow saw a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

FDA, Novavax and COVID-19 vaccine

Trending now